Literature DB >> 11069812

Unsuspected pseudophysiologic emphysema in chronic persistent asthma.

A F Gelb1, N Zamel.   

Abstract

The current literature emphasizes the role of airway remodeling in chronic persistent asthma and its putative effect on causing fixed expiratory airflow limitation. We studied 18 adults with chronic persistent asthma; 12 men, six women, age 59 +/- 15 yr (mean +/- SD) with fixed expiratory airflow obstruction. We measured lung elastic recoil and examined the mechanism of expiratory airflow limitation. Diaphragmatic strength was also measured in six asthmatics, using both sniff and partially occluded airway technique. All 18 asthmatics had markedly abnormal maximal expiratory flow-volume curves at both high and low lung volumes. Hyperinflation was present at residual volume (RV), FRC, and TLC in all subjects. Diffusing capacity was normal or elevated and lung computed tomography (CT) was normal in all 18 asthmatic subjects. There was a significant loss of lung elastic recoil in three of four asthmatics age 30 to 49, all five age 51 to 60 yr, and seven of nine age 61 to 82 yr. Maximal expiratory airflow limitation in only four elderly asthmatics and only at low lung volumes was due completely to loss of lung elastic recoil. In the others, we estimate the reduction in lung elastic recoil was responsible for 35% reduction in maximal expiratory airflow at 80% of TLC, and 55% at 70% of TLC. Despite hyperinflation, transdiaphragmatic pressures and strength were normal. The mechanisms responsible for loss of lung elastic recoil remain elusive. The high incidence of loss of lung elastic recoil in chronic persistent asthma was unexpected, and its contribution to abnormal lung function needs to be emphasized.

Entities:  

Mesh:

Year:  2000        PMID: 11069812     DOI: 10.1164/ajrccm.162.5.2001037

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  17 in total

1.  Bronchodilation response to deep inspirations in asthma is dependent on airway distensibility and air trapping.

Authors:  George Pyrgos; Nicola Scichilone; Alkis Togias; Robert H Brown
Journal:  J Appl Physiol (1985)       Date:  2010-11-11

2.  Irreversible airway obstruction in asthma.

Authors:  Louis-Philippe Boulet
Journal:  Curr Allergy Asthma Rep       Date:  2009-03       Impact factor: 4.806

Review 3.  Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome: Nothing New Under the Sun.

Authors:  Nirupama Putcha; Robert A Wise
Journal:  Immunol Allergy Clin North Am       Date:  2016-08       Impact factor: 3.479

4.  Persistent effects induced by IL-13 in the lung.

Authors:  Patricia C Fulkerson; Christine A Fischetti; Lynn M Hassman; Nikolaos M Nikolaidis; Marc E Rothenberg
Journal:  Am J Respir Cell Mol Biol       Date:  2006-04-27       Impact factor: 6.914

5.  Protective effects of basic fibroblast growth factor in the development of emphysema induced by interferon-γ.

Authors:  Byung-Jae Lee; Hyung-Geun Moon; Tae-Seop Shin; Seong Gyu Jeon; Eun-Young Lee; Yong Song Gho; Chun Geun Lee; Zhou Zhu; Jack A Elias; Yoon-Keun Kim
Journal:  Exp Mol Med       Date:  2011-04-30       Impact factor: 8.718

6.  Asthma and lung structure on computed tomography: the Multi-Ethnic Study of Atherosclerosis Lung Study.

Authors:  Kathleen M Donohue; Eric A Hoffman; Heather Baumhauer; Junfeng Guo; Firas S Ahmed; Gina S Lovasi; David R Jacobs; Paul Enright; R Graham Barr
Journal:  J Allergy Clin Immunol       Date:  2013-02       Impact factor: 10.793

Review 7.  Severe asthma.

Authors:  Nicholas J Kenyon; Nizar N Jarjour
Journal:  Clin Rev Allergy Immunol       Date:  2003-10       Impact factor: 8.667

Review 8.  Severe asthma: what makes it so hard to manage?

Authors:  Luke Carlstrom; Mario Castro
Journal:  Curr Allergy Asthma Rep       Date:  2009-09       Impact factor: 4.806

9.  Overlapping and enzyme-specific contributions of matrix metalloproteinases-9 and -12 in IL-13-induced inflammation and remodeling.

Authors:  Sophie Lanone; Tao Zheng; Zhou Zhu; Wei Liu; Chun Geun Lee; Bing Ma; Qingsheng Chen; Robert J Homer; Jingming Wang; Lesley A Rabach; Morgan E Rabach; J Michael Shipley; Steven D Shapiro; Robert M Senior; Jack A Elias
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

10.  Effect of fluticasone 250 microg/salmeterol 50 microg and montelukast on exhaled nitric oxide in asthmatic patients.

Authors:  Arthur F Gelb; Colleen Flynn Taylor; Chris M Shinar; Carlos A Gutierrez; Noe Zamel
Journal:  Can Respir J       Date:  2008 May-Jun       Impact factor: 2.409

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.